Ganaha F, Yamada T, Yorozu N, Ujita M, Irie T, Fukuda Y, Fukuda K, Tada S
Department of Radiology, Jikei University School of Medicine, Aoto Hospital, 6-41-2 Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Cardiovasc Intervent Radiol. 1999 Sep-Oct;22(5):436-8. doi: 10.1007/s002709900423.
We used a vascular access system (VAS) for continuous arterial infusion (CAI) of a protease inhibitor in two patients with acute necrotizing pancreatitis. The infusion catheter was placed into the dorsal pancreatic artery in the first patient and into the gastroduodenal artery in the second, via a femoral artery approach. An implantable port was then connected to the catheter and was secured in a subcutaneous pocket prepared in the right lower abdomen. No complications related to the VAS were encountered. This system provided safe and uncontaminated vascular access for successful CAI for acute pancreatitis.
我们对两名急性坏死性胰腺炎患者使用了血管通路系统(VAS)进行蛋白酶抑制剂的持续动脉输注(CAI)。通过股动脉途径,将输注导管置入第一名患者的胰背动脉和第二名患者的胃十二指肠动脉。然后将植入式端口连接到导管,并固定在右下腹制备的皮下袋中。未遇到与VAS相关的并发症。该系统为急性胰腺炎的成功CAI提供了安全且无污染的血管通路。